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Abstract   Using broadband near-infrared spectroscopy (NIRS) and cerebral mi-
crodialysis (MD) we investigated cerebral cellular metabolism and mitochondrial 
redox  states,  following  hypercapnoea  in  6  patients  with  traumatic  brain  injury 
(TBI). In all patients hypercapnoea increased intracranial pressure and cerebral 
blood flow velocity measured with transcranial Doppler. Despite the likely in-
crease in cerebral oxygen delivery, we did not see an increase in the oxidation 
status of cytochrome-c-oxidase [oxCCO] in every patient. Analysis of the NIRS 
data demonstrated two patterns of the changes; Group A (n=4) showed an increase 
in [oxCCO] of 0.34(±0.34)µM and Group B (n=2) a decrease of 0.40(±0.41)µM. 
Although no obvious association was seen between the ∆[oxCCO] and the MD 
measured  changes  in  lactate  and  pyruvate  concentrations,  further  work  using 
model informed data interpretation may be helpful in understanding the multi-
modal signals acquired in this heterogeneous patient group.   
1 Introduction 
Secondary cerebral damage after traumatic brain injury (TBI) is a multi-factorial 
process with two components being of key importance - reduction in oxygen de-
livery below critical thresholds and failing cellular metabolism leading to an in-
ability to utilise delivered oxygen and glucose. Global and regional derangements 
of cerebral oxygen delivery and utilisation often occur after TBI, rendering the 
brain susceptible to secondary injury processes. Modern protocolized TBI man-
agement strategies use a variety of modality techniques to monitor the injured brain and guide treatment. In addition within the context of attempting to mini-
mise secondary injury after TBI, it appears vital to ensure adequate O2 delivery to 
cerebral mitochondrial [1].  
Hypercapnoea causes cerebral vasodilatation and would therefore be expected to 
increase cerebral oxygen delivery and, in turn, promote cerebral glucose utiliza-
tion and oxidative metabolism to ensure maintenance of tissue high-energy phos-
phate reserves [2]. Using broadband near-infrared spectroscopy (BBS), we have 
recently demonstrated an increase in aerobic metabolism in the healthy human 
brain following hypercapnoea and hyperoxia [3] and during normobaric hyperoxia 
(NBH) after TBI [4]. The aim of this study was to investigate whether hypercap-
noea also cause changes in cellular and mitochondrial redox state in TBI. 
2 Methods 
This study was approved by the Joint Research Ethics Committee of the National 
Hospital for Neurology and Neurosurgery and the Institute of Neurology. As all 
patients were unconscious at the time of the study, written assent was obtained 
from their personal representatives. 6 adult patients (5 male and 1 female) with a 
mean age of 40 years (range 22-51 years) were recruited into the study. The mean 
time between injury and study was 106 hours (range 38-298 hours). 
Multimodality brain monitoring included intracranial pressure (ICP, Microsen-
sor, Codman), brain tissue O2 tension (PbrO2, Licox PMO, Integra Neurosciences) 
and cerebral microdialysis. Microdialysate glucose, lactate and pyruvate concen-
trations were measured at the bedside using a CMA 600 analyser (CMA Microdi-
alysis, Slona, Sweden). The mean blood flow velocity in the basal middle cerebral 
artery (Vmca) was measured using 2MHz transcranial Doppler ultrasonagraphy 
(Pioneer TC2020, Nicolet), as a surrogate of cerebral blood flow (CBF) [5]. For 
the purpose of this study the BBS optodes were placed 3.5cm apart in a black plas-
tic holder and fixed to the upper forehead near to the invasive cerebral monitoring. 
The BBS system has been described elsewhere [6]; briefly near-infrared spectra 
between 650 and 980nm were collected at 1Hz with a spectral resolution of 5 nm. 
Absolute  changes  in  concentrations  of  oxidised  minus  reduced  cytochrome-c-
oxidase ([oxCCO]), and oxygenated and deoxygenated haemoglobin concentra-
tions ([HbO2] and [HHb]) were calculated from changes in light attenuation. Cor-
rection factors for the wavelength dependence of the optical pathlength were ap-
plied  to  the  chromophore  absorption  coefficients.  The  individual  optical 
pathlength was calculated continuously using the second differential analysis of 
the 740nm water feature of the spectral data [7]. Change in total haemoglobin 
concentration ([HbT]) was derived from the sum of ∆[HbO2] and ∆[HHb].  
All patients received local protocolised intracranial pressure (ICP) and cerebral 
perfusion pressure (CPP) directed management based on international consensus 
guidance. During a period of cardiovascular stability, and whilst the patients were being mechanically ventilated, the minute ventilation was reduced in a stepwise 
manner to produce an increase in PaCO2 of approximately 1.5kPa. Cerebral mi-
crodialysate (MD) specimens were collected and analysed at intervals of 15-20min 
and arterial blood gases (ABG) for measurements of arterial carbon dioxide ten-
sion (PaCO2) and glucose concentrations were measured at intervals of 15-30min. 
All monitored variables were recorded on a personal computer and synchronised. 
Summary data were produced for the 2 phases of the study: baseline and hyper-
capnoea.  For  the  continuous  measured  variables  ([HbT],  [oxCCO],  ICP  and 
Vmca)  a 10 min mean and standard deviation for each phase were calculated, 
centred on the time of the ABG and MD sampling within that phase. Changes in 
the  continuously  measured  variables  between  baseline  and  hypercapnoea  were 
compared using a Student’s paired t-test (significance at p<0.05). Results are pre-
sented as mean +standard deviation. 
3 Results 
Group analysis demonstrated a significant mean increase in ICP (8.2±4.2mmHg), 
Vmca (25±18%), ∆[HbT] (4.02±4.91µM) and ∆[oxCCO] (0.1±0.5µM) during hy-
percapnoea. However not all patients demonstrated an increase ∆[oxCCO]; post-
hoc analysis demonstrated two patterns of change in ∆[oxCCO] in response to hy-
percapnoea. Group A had an increase of 0.34±0.34µM and Group B a decrease of 
-0.40±0.41µM (Figure 1and Table 1). Figure 2 shows a typical example of the 
changes recorded from a patient from each group. In Group A PaCO2 was signifi-
cantly increased from baseline by 1.5±0.8kPa, ICP by 8.9±4.6mmHg, [HbT] by 
3.27±5.73µM and Vmca by, 22±11.3%. In Group B PaCO2 was significantly in-
creased  from  baseline  by  2.1±1.1kPa,  ICP  by  6.8±4.5mmHg,  [HbT]  by 
5.53±3.92µM and Vmca by 31±34.3%.  
Table 1 Summary values for measured variables in Group A (4 patients) and Group B (2 pa-
tients) during baseline and hypercapnoea. Data presented as mean ±standard deviation.  
LPR is the lactate/pyruvate ratio; *Student’s paired t-test significance p<0.05. 
 
There was no association between the ∆[oxCCO] and the MD changes in lac-
tate and pyruvate at any time. However, during hypercapnoea the mean MD lac-
  Group A (n=4)    Group B (n=2)   
  Baseline  Hypercapnoea  Baseline  Hypercapnoea 
PaCO2 (kPa)  4.6(0.2)  6.1(0.7)  3.9(1.1)  6.0(0.0) 
∆Vmca (%)  -  22(11.3)*  -  31(34.3)* 
ICP (mmHg)  14.5(4.0)  23.4(7.9)*  7.5(5.5)  14.3(0.9)* 
LPR  23(10.1)  23(10.1)  20(5.5)  20(7.3) 
Lactate (mM)  4.9(2.7)  4.6(2.6)  3.4(1.6)  2.7(1.0) 
Pyruvate (µM)  209(27.3)  193(41.2)  166(32.5)  137(0.7) 
∆[oxCCO] (µM)  -  0.34(0.34)*  -  -0.40(0.41)* tate and pyruvate concentrations in Group A lay within reported normal levels and 
in Group B were at the low end and below reported normal levels respectively [8].  
4 Discussion 
We have previously demonstrated that an increase in cerebral oxygen delivery 
secondary to hypercapnoea and hyperoxia results in an increase in aerobic me-
tabolism in the healthy human brain [3]. We have also observed that NBH after 
TBI resulted in an increase in [oxCCO] consistent with an increase in aerobic me-
tabolism secondary to the induced increase in cerebral oxygen delivery [4]. Hy-
percapnoea would  be expected to increase cerebral  oxygen delivery via an in-
crease in cerebral blood flow (CBF). However, despite the increase in Vmca and 
[HbT] in all patients in this study, only four of the six patients showed an increase 
in the oxidation status of [oxCCO]. Interestingly, and unlike the situation with 
NBH, changes in MD measured metabolic variables were not associated with the 
changes in the oxidation status of [oxCCO].  
Unlike the effects of hyperoxia, hypercapnoea has multiple effects on cerebral 
physiology including CBF, pH, nitric oxide (NO) concentration and cerebral oxy-
gen consumption (CMRO2) and these might explain the variability of our results 
[9]. Also there is wide  heterogeneity  of pathophysiological changes after TBI, 
both between and within patients. In the latter, it is also important to note that 
global and regional changes also evolve with time or in response to treatment  
[10]. In individual patients, metabolic supply and demand varies substantially; hy-
permetabolism, therapeutic sedation leading to reduced metabolic requirements or 
mitochondrial dysfunction may all be present. Due to the large variation between 
the injury and the time of the study in our patient group the above variations could 
have affected our results. Further work is required to determine the relationship 
between  changes  in  the  continuous  optically  measured  metabolic  variable  [ox-
CCO]  (which  demonstrated  two  distinct  patterns  of  change  in  response  to  in-
creased cerebral oxygen delivery after hypercapnoea), and the non continuous MD 
variables lactate and pyruvate. To investigate this we have recently developed a 
mathematical model to interpret and predict cerebral physiological and biochemi-
cal variables [11]. It is possible that, through the use of a combination of multimo-
dal data collection and model informed data interpretation, we will be able to in-
crease  our  understanding of  our  measurements, characterize pathophysiological 
changes after TBI and potentially identify monitor-based, individualized treatment 
strategies. 
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Fig. 1 Mean changes from baseline for each TBI patient.  
 
Patient 6  Patient 1  Patient 4  Patient 5  Patient 2  Patient 3 Fig. 2 In patient 3 intracerebral lactate and pyruvate concentrations dropped and significant re-
duction in oxCCO was also observed. In patient 5 there were no changes in lactate and pyruvate 
and a significant oxidation in oxCCO was seen. Even though the intracerebral oxygenation levels 
increased in both patients as seen by the measured PbrO2 significant differences were observed 
in the metabolic variables suggesting a possible decrease in aerobic metabolism in patient 3. 
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